IP Library Granted Patent US 7,985,386
Granted Patent B2
US 7,985,386 · App. 12/240,728 · Granted Jul 26, 2011

Implantable medical device for diagnostic sensing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,985,386
App. No.
12/240,728
Granted
Jul 26, 2011
Kind
B2
Abstract

An implantable medical device is provided for use with an external detector to detect an analyte in vivo. In one embodiment, the device consisting essentially of a substrate; a plurality of discrete reservoirs located in the substrate, each reservoir having at least one opening; a reacting component contained in each reservoir; and at least one non-degradable barrier layer covering each reservoir opening, the barrier layer being permeable to an analyte to be detected, wherein the reacting component remains inside the reservoirs and can react with the analyte to be detected, and wherein the device is adapted for implantation into the body of a patient.

Claims (15)

1. An implantable medical device for use in analyte detection consisting essentially of:

a substrate;

a plurality of discrete reservoirs located in the substrate, each reservoir having at least one opening;

at least one reacting component contained in each reservoir;

at least one non-degradable barrier layer covering each reservoir opening, the barrier layer being permeable to an analyte to be detected, wherein the at least one non-degradable barrier layer comprises a semi-permeable polymeric membrane;

wherein the reacting component remains inside the reservoirs and can undergo a binding reaction with the analyte to be detected, the binding reaction being detectable by a sensor positioned outside of the device; and

at least one degradable barrier layer covering each reservoir opening, wherein said degradable barrier layer is adapted to degrade in vivo to permit said binding reaction to occur.

2. The device of claim 1 , wherein the at least one degradable barrier layer comprises a degradable polymer.

3. The device of claim 1 , wherein the at least one degradable barrier layer comprises a metal film and the device further includes a power source and control circuitry for disintegrating the metal film.

4. The device of claim 1 , wherein the substrate comprises a polymer.

5. The device of claim 1 , which is adapted to be implanted in a patient by injection.

6. The device of claim 1 , wherein the at least one reacting component comprises a metal.

7. The device of claim 1 , wherein the at least one reacting component comprises a nucleic acid or polysaccharide.

8. The device of claim 1 , wherein the at least one reacting component is in a solid form.

9. The device of claim 1 , wherein the at least one reacting component is in a suspension within the reservoirs.

Assignments (1)
CHANGE OF NAME Recorded Jun 28, 2016
From: MICROCHIPS, INC.
To: MICROCHIPS BIOTECH, INC.
Reel/Frame 039027/0671 →